We invite interested external parties to submit their project proposals (see below). In order for our internal review process to run as quickly and smoothly as possible, we encourage the inclusion of any non-confidential data describing the compound or technology in more detail. This will ensure a comprehensive and fair review by our internal experts.
Our global research efforts begin and end with the patient.
Products in development
Pharmaceutical business at Novartis
Novartis discovers and develops innovative medicines with improved efficacy and fewer side-effects.